Seneca Biopharm Inc (SNCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNCA | PTN | APRE | ||
| Company | Seneca Biopharm Inc | Palatin Technologies | Aprea Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 9.9000 | 1.7600 | 5.01 | ||
| High | 10.0278 | 1.8500 | 5.26 | ||
| Low | 9.7200 | 1.7500 | 5.00 | ||
| Last | 9.9600 | 1.7900 | 5.08 | ||
| Change | -0.1200 | -0.0300 | -0.12 | ||
| % Change | -1.19% | -1.65% | -2.22% | ||
| Volume | 194,116 | 81,300 | 2,500 | ||
| 20-Day Average Volume | 1,882,520 | 841,365 | 7,130 | ||
| Previous Close | 10.0800 | 1.8200 | 5.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.6135 | 1.8330 | 5.78 | ||
| 20-Day Raw Stochastic | 58.18% | 12.10% | 4.96% | ||
| 20-Day Relative Strength | 52.73% | 45.07% | 40.95% | ||
| Weighted Alpha | +97.27 | -39.98 | +12.69 | ||
| Today's Opinion | 96% Buy | 88% Sell | 8% Buy | ||
| Previous Opinion | 96% Buy | 88% Sell | 24% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.16% since 04/20/21 | +4.07% since 04/22/24 | -0.70% since 04/22/24 | ||
| Low | 1.4501 on 04/21/21 | 1.6600 on 04/25/24 | 5.00 on 04/29/24 | ||
| High | 1.8800 on 04/26/21 | 1.8500 on 04/29/24 | 5.62 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +7.10% since 03/26/21 | -4.28% since 03/28/24 | -24.00% since 03/28/24 | ||
| Low | 1.3400 on 04/16/21 | 1.6400 on 04/03/24 | 5.00 on 04/29/24 | ||
| High | 1.8900 on 04/06/21 | 2.8800 on 04/08/24 | 6.70 on 04/03/24 | ||
| 3-Month | |||||
| %Chg | +22.96% since 01/27/21 | -67.22% since 01/29/24 | -0.11% since 01/29/24 | ||
| Low | 1.0301 on 03/04/21 | 1.4600 on 03/20/24 | 4.94 on 02/01/24 | ||
| High | 2.6700 on 03/22/21 | 5.2200 on 01/31/24 | 8.85 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | +167.74% since 10/27/20 | -8.67% since 10/27/23 | +43.71% since 10/27/23 | ||
| Low | 0.5394 on 11/05/20 | 1.4600 on 03/20/24 | 3.35 on 10/31/23 | ||
| High | 2.6700 on 03/22/21 | 5.6500 on 01/29/24 | 8.85 on 03/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 28,711 | 29,369 | 28,237 | ||
| Shares Outstanding, K | 17,296 | 16,137 | 5,430 | ||
| Annual Sales | 10,000 | 4,850,000 | 580,000 | ||
| Annual Net Income | -16,270,000 | -27,540,000 | -14,290,000 | ||
| Last Quarter Sales | 2,500 | 2,030,000 | 10,000 | ||
| Last Quarter Net Income | -4,418,839 | -7,840,000 | -3,440,000 | ||
| 60-Month Beta | 1.88 | 0.93 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.56 on 02/14/24 | -0.92 on 03/26/24 | ||
| Latest Earnings Date | 05/21/21 | 05/21/24 | 05/20/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||